Abstract:Objectives The incidence of VTE in patients undergoing EPS and RFCA is considerable high. Procedure duration is potential to be a risk factor of TE. Better pharmacological thromboprophylaxis is considered to be essential, particularly in those patients with potential risk factors. Methods A prospective study was conducted from February 2003 to August 2006 in our clinic. A total of 348 patients with EPS (n=231) and RFCA (n=117) were analysed. For the diagnosis of DVT, Duplex ultrasonography evaluation of the bilateral femoral veins was performed after the procedure. Lung ventilation/perfusion scintigraphy was carried out in patients suspected to have PTE. An initial bolus of 3000 IU heparin was injected to all patients, and additional heparin was supplied when the activated clotting time (ACT) was less than 300 s during the procedure. Results There were 38 patients with DVT (10.9%) and one patient of them was diagnosed as PTE (0.3%). With univariate analysis, the procedure duration and the number of the introducer sheaths were identified as a significant risk factor in the whole study population. When analysed by the stepwise multiple logistic regression model, only the procedure duration risk factor was found to be significant (OR=1.008, 95% CI 1.001 to 1.015). While, both ablation (OR=1.330, 95% CI 0.666 to 2.658) and adipositas (OR=0.808, 95% CI 0.402 to 1.621) did not appear to be related to TE. Smoking habit influenced negatively the incidence of VTE (OR=0.311, 95% CI 0.107 to 0.904). Pretreatment of aspirin had no relation to the occurrence of VTE (OR=1.055, 95% CI 0.5372 to 2.072). Additional heparin was required most in the patients with RF ablation, more introducer sheaths and longer length of duration to maintain the ACT more than 300 s during the procedure. The incidence of VTE in patients with additional heparin was significant high than the patients without additional heparin. Certain attention should be drawn on patients with potential risk factors, and the ACT measurement should be repeated to maintenance at an adequate level. Conclusions The incidence of VTE in patients undergoing EPS and RFCA is considerable high. Procedure duration is potential to be a risk factor of TE. Better pharmacological thromboprophylaxis is considered to be essential, particularly in those patients with potential risk factors.

The incidence and treatment of deep venous thrombosis of upper extremities after implantation of cardiac pacemaker.

Incidence and long-term outcomes of upper limb deep vein thrombosis associated with intracardiac devices: analysis of bleeding, recurrence, and sequelae

The incidence and clinical characteristics of femoral vein thrombus after leadless pacemaker implantation

The Incidence of Venous Thromboembolism and Its Risk Factors Following Electrophysiologic Study and Radiofrequency Catheter Ablation in Patients with Cardiac Arrhythmia

A case of upper extremity deep vein thrombosis with long-term patency using pharmaco-mechanical catheter-directed thrombolysis in the acute phase

Incidence and Predictors of Permanent Pacemaker Implantation in Patients Who Underwent Transcatheter Aortic Valve Replacement: Observation of a Chinese Population.

Efficacy of percutaneous mechanical thrombus removal in acute lower extremity deep venous thrombosis

Thromboembolic Events During the Perioperative Period in Patients Undergoing Permanent Pacemaker Implantation

Postoperative Complications of Surgical Therapy for Deep Vein Thrombosis (DVT) of the Lower Extremity

Intramural Hematoma and Acute Pulmonary Embolism Following Pacemaker Implantation: A Case Report

Analysis of complications after pacemaker implantation 82 cases

Using point‐of‐care ultrasound to determine incidence of deep vein thrombosis after right‐sided radiofrequency catheter ablation

Deep vein thrombosis and pulmonary embolism after heart transplantation

Catheter Directed Thrombolysis for Treatment of Acute Deep Venous Thrombosis of the Lower Extremity of the Effect and Safety Analysis in 116 Cases

The Application of Assistant Catheterization Technique in Interventional Treatment of Deep Venous Thrombosis of Left Lower Extremity

Axillary and subclavian venous spasm during pacemaker implantation - A case report and literature review

Progress in Diagnosis and Treatment of Deep Venous Thrombosis after Total Joint Arthroplasty

The short-term outcome of residual thrombus of the lower extremity after pharmacomechanical catheter-directed thrombolysis for deep vein thrombosis

Troponin T elevation after permanent pacemaker implantation

Perioperative complications after pacemaker implantation: higher complication rates with subclavian vein puncture than with cephalic vein cutdown

[Effects of Primary Deep Venous Valvular Incompetence of Lower Limb in Deep Vein Thrombus after Total Knee Replacement].